Metformin disrupts malignant behavior of oral squamous cell carcinoma via a novel signaling involving Late SV40 factor/Aurora-A - Chen, Chang-Han; Tsai, Hsin-Ting; Chuang, Hui-Ching; Shiu, Li-Yen; Su, Li-Jen; Chiu, Tai-Jan; Luo, Sheng-Dean; Fang, Fu-Min; Huang, Chao-Cheng; Chien, Chih-Yen (Scientific Reports, 2017)
Keywords: 13/105; 13/109; 13/51; 13/89; 13/95; 14/19; 631/67/1536; 64/60; 692/4028/67; 96/1; Antidiabetics; Antineoplastic Agents; Aurora Kinase A; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; DNA-Binding Proteins; Down-Regulation; Humanities and Social Sciences; Humans; Malignancy; Medicine; Metastases; Metformin; Mouth Neoplasms; multidisciplinary; Oral cancer; Oral squamous cell carcinoma; Q; R; Science; Science (multidisciplinary); Signal Transduction; Squamous cell carcinoma; Survival; Transcription Factors; Tumorigenesis; Xenograft Model Antitumor Assays; Xenografts